Research interests include Ubiquitin and proteasome pathways, Cancer-related Molecular Pathways, Epigenetics and DNA Methylation, and RNA modifications and cancer.
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer: final analysis of the randomized RATIONALE-315 trial
Annals of Oncology2025cited by 3position: middledoi
MiR-138 suppressed nasopharyngeal carcinoma growth and tumorigenesis by targeting the CCND1 oncogene